testtailortreat.com.au
Erbitux®(cetuximab) PSP for metastatic colorectal cancer (mCRC) HEALTHCARE PROFESSIONAL INFORMATION Background Erbitux® (cetuximab) is approved in Australia for the treatment of epidermal growth receptor (EGFR)-expressing, K-RAS wild-type metastatic colorectal cancer (mCRC): • in combination with infusional 5-fluorouracil/folinic acid plus irinotecan • in combination with irinotecan in